Article
COLD-PCR Technologies in the Area of Personalized Medicine: Methodology and Applications.
Molecular diagnosis & therapy - 1 Jun 2017
Mauger Florence, How-Kit Alexandre, Tost Jörg
Abstract excerpt
Somatic mutations bear great promise for use as biomarkers for personalized medicine, but are often present only in low abundance in biological material and are therefore difficult to detect. Many assays for mutation analysis in cancer-related genes (hotspots) have been developed to improve diagnosis, prognosis, prediction of drug resistance, and monitoring of the response to treatment. Two major approaches have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
